Maximus, Inc. (NYSE:MMS) Stake Trimmed by Orion Portfolio Solutions LLC

Orion Portfolio Solutions LLC lowered its stake in Maximus, Inc. (NYSE:MMSFree Report) by 7.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 16,902 shares of the health services provider’s stock after selling 1,414 shares during the quarter. Orion Portfolio Solutions LLC’s holdings in Maximus were worth $1,316,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently bought and sold shares of the company. VisionPoint Advisory Group LLC increased its stake in Maximus by 61.4% in the 3rd quarter. VisionPoint Advisory Group LLC now owns 381 shares of the health services provider’s stock worth $28,000 after purchasing an additional 145 shares in the last quarter. Anchor Investment Management LLC purchased a new position in Maximus in the 4th quarter worth about $32,000. Planned Solutions Inc. purchased a new position in Maximus in the 4th quarter worth about $59,000. Fifth Third Bancorp increased its stake in Maximus by 57.9% in the 4th quarter. Fifth Third Bancorp now owns 998 shares of the health services provider’s stock worth $84,000 after purchasing an additional 366 shares in the last quarter. Finally, NBC Securities Inc. purchased a new position in Maximus during the 3rd quarter valued at about $85,000. Hedge funds and other institutional investors own 97.21% of the company’s stock.

Analyst Ratings Changes

Separately, StockNews.com raised Maximus from a “hold” rating to a “buy” rating in a research note on Thursday, February 8th.

View Our Latest Analysis on MMS

Maximus Trading Up 1.1 %

Shares of NYSE MMS opened at $86.10 on Friday. The stock has a market cap of $5.23 billion, a price-to-earnings ratio of 22.60 and a beta of 0.72. The business has a 50 day simple moving average of $82.96 and a 200 day simple moving average of $82.83. Maximus, Inc. has a 52 week low of $72.39 and a 52 week high of $90.65. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.53 and a current ratio of 1.53.

Maximus (NYSE:MMSGet Free Report) last announced its quarterly earnings results on Wednesday, May 8th. The health services provider reported $1.57 EPS for the quarter, beating the consensus estimate of $1.31 by $0.26. The business had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.29 billion. Maximus had a return on equity of 18.02% and a net margin of 4.58%. The firm’s quarterly revenue was up 11.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.80 EPS. On average, research analysts predict that Maximus, Inc. will post 5.79 earnings per share for the current fiscal year.

Maximus Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, May 31st. Investors of record on Wednesday, May 15th were paid a $0.30 dividend. The ex-dividend date of this dividend was Tuesday, May 14th. This represents a $1.20 annualized dividend and a dividend yield of 1.39%. Maximus’s payout ratio is 31.50%.

Maximus Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Further Reading

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.